[ad_1] IvelinRadkov AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) stated {that a} Phase 3 examine of their antibody drug conjugate, or ADC, datopotamab deruxtecan didn’t present…
Browsing: Phase
[ad_1] Krystal Biotech’s Jeune reports promising phase 1 data on wrinkles drug [ad_2] Source: (*1*)
(*3*) Palatin stock climbs 8% on Phase 3 testing update for PL9643 [ad_2] Source: Seekingalpha